Human relevance of NRAS/BRAF mouse melanoma models

被引:13
|
作者
Conde-Perez, Alejandro [1 ,2 ,3 ]
Larue, Lionel [1 ,2 ,3 ]
机构
[1] Inst Curie, F-91405 Orsay, France
[2] CNRS, UMR3347, F-75700 Paris, France
[3] INSERM, U1021, F-75654 Paris 13, France
关键词
PTEN; beta-Catenin; p16(INK4A); Melanomagenesis; Initiation; Progression; BETA-CATENIN; CUTANEOUS MELANOMA; GENERAL STRATEGY; PTEN; BRAF; MUTATIONS; EXPRESSION; SENESCENCE; PATHWAYS; SKIN;
D O I
10.1016/j.ejcb.2013.10.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Melanoma is a major problem for many individuals worldwide. Although no effective treatment is available, promising new strategies are being developed. A better understanding of the inner workings of the disease would undoubtedly lead to improved treatments. Mouse melanoma models have been used to elucidate many key regulatory pathways involved in melanoma initiation and progression, and models with mutations in the oncogenes RAF and RAS have been particularly informative. Here, we summarize and evaluate the human relevance of various RAF and RAS mouse melanoma models and their contribution to our understanding of melanoma. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:82 / 86
页数:5
相关论文
共 50 条
  • [31] Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes
    Thomas, Nancy E.
    Edmiston, Sharon N.
    Orlow, Irene
    Kanetsky, Peter A.
    Luo, Li
    Gibbs, David C.
    Parrish, Eloise A.
    Hao, Honglin
    Busam, Klaus J.
    Armstrong, Bruce K.
    Kricker, Anne
    Cust, Anne E.
    Anton-Culver, Hoda
    Gruber, Stephen B.
    Gallagher, Richard P.
    Zanetti, Roberto
    Rosso, Stefano
    Sacchetto, Lidia
    Dwyer, Terence
    Ollila, David W.
    Begg, Colin B.
    Berwick, Marianne
    Conway, Kathleen
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (11) : 2398 - 2404
  • [32] Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
    Goel, Vikas K.
    Lazar, Alexander J. F.
    Warneke, Carla L.
    Redston, Mark S.
    Haluska, Frank G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (01) : 154 - 160
  • [33] BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma
    Kim, Jinhyun
    Lazar, Alexander J.
    Davies, Michael A.
    Homsi, Jade
    Papadopoulos, Nicholas E.
    Hwu, Wen-jen
    Bedikian, Agop Y.
    Woodman, Scott E.
    Patel, Sapna P.
    Hwu, Patrick
    Kim, Kevin B.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2012, 39 (09) : 821 - 825
  • [34] New therapies for the treatment of BRAF/NRAS wild type melanoma
    Ranzani, Marco
    Kemper, Kristel
    Michaut, Magali
    Krijgsman, Oscar
    Iyer, Vivek
    Speak, Anneliese
    Nsengimana, Jeremie
    Wong, Kim
    Grinkevich, Vera
    Aben, Nanne
    Velasco-Herrera, Martin Del Castillo
    Alsinet, Clara
    Sjoberg, Marcela
    Rashid, Mamunur
    Turner, Gemma
    Behan, Fiona
    Supper, Emmanuelle
    Thompson, Nicola
    Bignell, Graham
    Dutton-Regester, Ken
    Pritchard, Antonia
    Wong, Chi
    McDermott, Ultan
    Hayward, Nicholas K.
    Yusa, Kosuke
    Newton-Bishop, Julia
    Wessels, Lodewyk
    Garnett, Mathew
    Peeper, Daniel
    Adams, David
    CANCER RESEARCH, 2017, 77
  • [35] Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma
    Houben, Roland
    Vetter-Kauczok, Claudia S.
    Ortmann, Sonja
    Rapp, Ulf R.
    Broecker, Eva B.
    Becker, Juergen C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (08) : 2003 - 2012
  • [36] Modeling BRAF inhibitor resistance in genetically engineered mouse models of melanoma
    Kwong, Lawrence N.
    Jiang, Shan
    Chin, Lynda
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [37] Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma (vol 17, pg 229, 2011)
    Ellerhorst, J. A.
    Greene, V. R.
    Ekmekcioglu, S.
    Warneke, C. L.
    Johnson, M. M.
    Cooke, C. P.
    CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1641 - 1641
  • [38] BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced Melanoma
    van Not, Olivier J.
    Blokx, Willeke A. M.
    van den Eertwegh, Alfons J. M.
    de Meza, Melissa M.
    Haanen, John B.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    de Groot, Jan Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Boers-Sonderen, Marye J.
    Jansen, Anne M. L.
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn P. M.
    JCO PRECISION ONCOLOGY, 2022, 6
  • [39] BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study
    Frank, Georgiy A.
    Aleksakhina, Svetlana N.
    Zavalishina, Larisa E.
    Kekeyeva, Tatiana V.
    Venina, Aigul R.
    Ivantsov, Alexandr O.
    Mitiushkina, Natalia V.
    Moiseyenko, Alla V.
    Pfeifer, Werner
    Strelkova, Tatiana N.
    Imyanitov, Evgeny N.
    MELANOMA RESEARCH, 2016, 26 (05) : 442 - 447
  • [40] Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation
    Brandon M. Murphy
    Elizabeth M. Terrell
    Venkat R. Chirasani
    Tirzah J. Weiss
    Rachel E. Lew
    Andrea M. Holderbaum
    Aastha Dhakal
    Valentina Posada
    Marie Fort
    Michael S. Bodnar
    Leiah M. Carey
    Min Chen
    Craig J. Burd
    Vincenzo Coppola
    Deborah K. Morrison
    Sharon L. Campbell
    Christin E. Burd
    Nature Communications, 13